What's new

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Feb 28, 2025 - 16:08
 0
Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Archer announces fourth quarter & full year 2024 results, sets plans for Midnigh...

Next Article

China’s Zara Tries Going Global in Hopes of Shein-Like Success

Related Posts

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 February 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025 to 13 February 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 10 ...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0